Akthelia Pharmaceuticals

Akthelia Pharmaceuticals is a preclinical-stage biopharmaceutical company aimed at improving cancer treatment and the outcomes of cell and organ transplantation by enhancing efficacy and reducing the major risk factors associated with current cytotoxic chemotherapy.